The Rise of GLP-1 Weight Loss Drugs and Public Health Implications
A new wave of weight-loss medications is making headlines, with drugs like Ozempic, Wegovy, and Mounjaro not only aiding in significant weight reduction but also showing promise in improving cardiovascular health post-heart attack. These medications, categorized as GLP-1 receptor agonists, are seeing increasing use due to their efficacy. However, their popularity raises questions about the […]
Read more →